IDDK Co., Ltd., which owns its proprietary semiconductor sensor-based microscopic observation technology MID to provide space bio-experiment services (CEO: Soichiro Ueno, headquartered in Tokyo, hereinafter referred to as IDDK), has, by November 28, 2023, completed the first close of its Pre-Series A round with Space Frontier Fund (SPARX Innovation for Future Co., Ltd.) and Samurai Incubate Fund Ⅶ Investment Limited Partnership (Samurai Incubate Inc.).
INFORMATION
ENGLISH